ArticleBMC public health2025
Global to local burden and inequalty of low respiratory infections among children and adolescents across 953 locations.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Burden of 46 key pathogens among children in G20 countries, 2023: A systematic analysis and regional comparison.PLoS neglected tropical diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAdolescent lower respiratory infections (LRIs) are one of the major public health problems worldwide. Utilizing data from Global Burden of Disease 2021 (GBD 2021), this study aimed to investigate the trends and distribution characteristics of the burden of LRIs among children and adolescents from global to local levels, as well as to assess inequalities in disease burden. Unlike previous GBD reports, our analysis provides unprecedented subnational resolution across 953 global locations, uncovering local inequalities often masked in national-level estimates.
methodsWe conducted an extensive analysis of the impact of LRIs across 953 global regions. This investigation included various metrics, including prevalence, incidence, mortality, disability-adjusted life years (DALYs), years of life lost (YLLs) and years lived with disability (YLDs). Additionally, we performed an inequality analysis and a frontier analysis pertinent to the sociodemographic index (SDI).
resultsFrom 1990 to 2021, the incidence rate among adolescents decreased by 55.8%, and the DALYs rate decreased by 76.7%. Mortality rates decreased from 127.7 (95% uncertainty interval [UI]: 110.9 to 149.7) in 1980 to 21.2 (95% UI: 17.5 to 25.5) in 2021. In 2021, there were still 1.8 million adolescents worldwide suffering from LRIs. Among 652 local administrative regions, Mandera in Kenya had the highest incidence rate at 7,743.6 (95% UI: 6,876.8-8,715.6), and Sokoto in Nigeria had the highest DALYs rate at 16,663.3 (95% UI: 11,825.8-22,776.3). Since 1990, the global burden of LRIs among adolescents has significantly decreased, but regional disparities remain significant. From 1990 to 2021, the slope index of inequality (SII) for incidence rates and DALYs rates decreased by 56.8% and 81.5%, respectively, with higher disease burdens in low- and low- middle-SDI regions. In 2021, only 14.2% reached the incidence rate frontier level, and 15.2% reached the DALYs rate frontier level.
conclusionsSubstantial progress has been made in reducing the burden of LRIs, but the burden remains heavy, particularly in low- and low- middle SDI regions. Trend analysis provides scientific evidence for international aid and policy-making to address inequalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.